Indole Sulfonyl Hydroxamic Acid HDAC Inhibitors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The development of sulfonyl hydroxamic acid derivatives with selective HDAC inhibition properties is challenging, and there is a need for the synthesis and biological evaluation of diversely substituted indole-based sulfonyl hydroxamic acid compounds, which are rare and underexplored for their biological properties.
Innovation Solution
The synthesis of novel sulfonyl hydroxamic acid derivatives with an indole core, specifically through steps involving bromination, protection of indole NH, reduction of the nitro group, base-mediated coupling, Suzuki reaction, and installation of the hydroxamic acid, resulting in compounds like N-hydroxy-4-(N-(1-methyl-3-aryl-1H-indol-5-yl)sulfamoyl)benzamide, which are tested for HDAC inhibition activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If novel indole-based sulfonyl hydroxamic acid derivatives are synthesized to achieve selective HDAC inhibition, then new chemical entities with therapeutic potential are obtained, but the synthesis complexity and number of steps increase
Solution Approach 1:
The synthesis is divided into distinct modular steps: bromination of indole, protection of NH group, nitro group reduction, sulfonyl coupling, Suzuki reaction for aryl group introduction, and hydroxamic acid installation. Each step is optimized independently to achieve high yields and selectivity, resolving the contradiction between complex molecule synthesis and process manageability
Solution Approach 2:
The indole NH group is protected with a methyl group in an early step before subsequent transformations. This preliminary protection prevents unwanted side reactions during bromination and coupling steps, ensuring high selectivity for the desired HDAC inhibitor structures while simplifying the overall synthesis pathway
2Adaptability or versatility
If diversely substituted indole derivatives are prepared to explore structure-activity relationships, then selective HDAC inhibitors are identified, but the number of synthesis steps and time required increase
Solution Approach 1:
The synthetic route establishes a universal platform where the core indole-sulfonyl-hydroxamic acid structure can accommodate diverse aryl substituents through the Suzuki reaction. By standardizing the core structure and using modular aryl boronic acid coupling partners, multiple analogs with different R groups can be synthesized from a common intermediate, enabling efficient structure-activity relationship exploration
Solution Approach 2:
The methodology systematically varies substituent parameters on the aryl groups (electron-withdrawing/donating groups, position of substitution, heteroatom types) while maintaining the core structure. This parameter-based approach allows rapid generation of diverse compounds with optimized HDAC selectivity and potency, reducing the time required for SAR studies
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These derivatives exhibit selective HDAC inhibition properties, providing new chemical entities for drug discovery and showing potential in treating various diseases, including cancer and neurodegenerative disorders, with efficient synthetic protocols and high yields.
Implementation Method 1
bromination of nitroindole using brominating reagents in polar non-protonated solvents at -5 to 5 °C for 40-100 minutes
Implementation Method 2
reduction of nitro group to amine using metal reducing reagent in polar solvent mixture at -5 to 5 °C for 40-100 minutes
Implementation Method 3
base mediated coupling between sulfonyl and amine functionalities in polar solvent at 25-40 °C for 12-24 hours
Implementation Method 4
suzuki reaction/coupling using boronic acid derivative, palladium catalyst and phosphate salt in polar solvent 70-100 °C for 5-10 hours
Data Source
Figure 1
Figure 2(a)~2(b)
AI summary
The present invention provides the sulfonyl hydroxamic acid compounds of general formulae (I) useful as HDAC inhibitors and process for preparation of these indole based sulfonyl hydroxamic acid derivatives. wherein ring A and B is aryl or heteroaryl or cycloalkyl or fused aryl or fused alkyl group; R1, R2, R3, R4, R5, R6 is hydrogen, alkoxy, aryloxy, hydroxy, ester, amide, amino, alkyl, aryl, heteroaryl, halogen, hydroxy, alkoxy, aryloxy, nitro, cyano, ester, aldehyde.